Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Resectable Non-Small Cell Lung Cancer × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 222 Lung Neoplasms 145 Breast Neoplasms 33 Small Cell Lung Carcinoma 30 Neoplasms 23 Mesothelioma, Malignant 14 Neoplasm Metastasis 13 Adenocarcinoma of Lung 13 Stomach Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Ovarian Neoplasms 11 Mesothelioma 11 Colorectal Neoplasms 11 Melanoma 10 Prostatic Neoplasms 9 Brain Neoplasms 9 Pancreatic Neoplasms 8 Esophageal Neoplasms 8 Carcinoma, Renal Cell 8 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 5 Triple Negative Breast Neoplasms 5 Sarcoma 5 Colonic Neoplasms 5 Kidney Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Carcinoma 4 Adenocarcinoma 4 Testicular Neoplasms 3

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡